查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951853

单细胞分析市场分析及预测（至2035年）：依类型、产品类型、服务、技术、应用、最终用户、组件、製程及模式划分

Single-cell Analysis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Process, Mode
出版日期: | 出版商: Global Insight Services | 英文 381 Pages | 商品交期: 3-5个工作天内

价格
简介目录

单细胞分析市场预计将从2024年的31亿美元成长到2034年的110亿美元，复合年增长率约为12.7%。单细胞分析市场涵盖用于分析单一细胞的技术和调查方法，能够深入了解细胞异质性和微环境。该市场包括仪器、耗材和软体，可实现单细胞层级的基因组学、转录组学和蛋白​​质组学分析。市场成长的驱动力来自对精准医疗日益增长的需求以及生物技术的进步，这些因素共同推动了单细胞分析在肿瘤学、免疫学、干细胞研究等领域的应用。微流体、定序和生物资讯学的创新正在提升细胞分析的分辨率和通量。

受基因组技术和个人化医疗发展趋势的推动，单细胞分析市场正经历强劲成长。其中，耗材领域成长最为显着，这主要得益于单细胞实验所需试剂和检测试剂盒的需求。仪器设备，尤其是流式细胞仪和次世代定序平台，紧随其后，体现了它们在数据收集和分析方面的重要作用。软体和服务领域也呈现成长势头，生物资讯学工具和数据分析服务对于解读复杂的单细胞数据至关重要。此外，肿瘤学应用也推动了市场成长，这主要源自于对更精准的癌症诊断和治疗策略的需求。免疫学应用领域也不断扩张，印证了免疫分析在疾病研究中的重要性。对单细胞RNA定序的日益关注进一步推动了市场扩张，为深入了解细胞异质性和功能提供了前所未有的视角。

市场区隔
类型 耗材、设备和软体
产品 试剂、检测试剂盒、微孔盘、磁珠、设备
服务 细胞分离、单细胞基因体学、单细胞蛋白质体学、单细胞转录体学
科技 流式细胞技术、质谱分析、显微镜、次世代定序
应用领域 癌症研究、神经学、免疫学、干细胞研究、微生物学
最终用户 学术和研究实验室、生物技术和製药公司、医院和诊断实验室
成分 硬体、软体和服务
过程 细胞活力评估、细胞鑑定、细胞计数
模式 自动化、手动

单细胞分析市场格局瞬息万变，大型生技公司占了相当大的市场。定价策略竞争激烈，反映了该领域的创新性和最尖端科技的不断涌现。近期推出的产品主要致力于提高精度和扩充性，以满足日益增长的个人化医疗和先进研究应用需求。在技​​术进步和研发投入不断增加的推动下，市场正经历强劲成长。单细胞分析市场的竞争异常激烈，主要参与者透过策略联盟和创新争夺主导。监管因素，尤其是在北美和欧洲，包括严格的产品品质和安全标准，影响市场动态。基准研究表明，拥有强大研发能力和全面产品系列的公司保持着竞争优势。在肿瘤学、免疫学和干细胞研究领域单细胞技术应用日益广泛的推动下，市场预计将持续成长。儘管监管合规和高昂的营运成本等挑战依然存在，但医疗保健领域变革性突破的潜力蕴藏着盈利的商机。

主要趋势和驱动因素：

受基因组技术和个人化医疗进步的推动，单细胞分析市场正经历显着成长。关键趋势包括人工智慧 (AI) 和机器学习的融合，不仅提升了数据分析和解读能力，还能更深入地洞察细胞行为。对高通量定序技术的需求也在不断增长，从而实现更全面、更经济高效的单细胞研究。推动该市场发展的因素包括慢性病发病率的上升以及对个人化治疗方案的需求。研究人员致力于在细胞层面阐明疾病机制，这推动了单细胞分析在肿瘤学和免疫学领域的应用。此外，政府资助和私人投资正在加速研发活动，促进该领域的创新。学术机构和产业界之间的合作也在迅速增加，以将研究成果转化为临床应用。在医疗基础设施不断改善、研究活动日益活跃的发展中地区，也涌现新的机会。能够提供扩充性且易于使用的解决方案的公司，预计将占据可观的市场份额。人们对精准医疗和疾病早期检测的兴趣日益浓厚，这进一步支撑了单细胞分析市场的持续成长潜力。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 消耗品
    • 装置
    • 软体
  • 市场规模及预测：依产品划分
    • 试剂
    • 检测试剂盒
    • 微孔盘
    • 珠
    • 装置
  • 市场规模及预测：依服务划分
    • 细胞分离
    • 单细胞基因体学
    • 单细胞蛋白质体学
    • 单细胞转录组学
  • 市场规模及预测：依技术划分
    • 流式细胞技术
    • 质谱分析
    • 显微镜
    • 次世代定序
  • 市场规模及预测：依应用领域划分
    • 癌症研究
    • 神经病学
    • 免疫学
    • 干细胞研究
    • 微生物学
  • 市场规模及预测：依最终用户划分
    • 学术与研究机构
    • 生物技术和製药公司
    • 医院和诊断检查室
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
  • 市场规模及预测：依製程划分
    • 细胞活力评估
    • 细胞鑑定
    • 细胞计数
  • 市场规模及预测：按模式
    • 自动化
    • 手动的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Fluidigm
  • 10x Genomics
  • Mission Bio
  • Bio-Rad Laboratories
  • Takara Bio
  • Nano String Technologies
  • Illumina
  • BD Biosciences
  • Berkeley Lights
  • Cytek Biosciences
  • S2 Genomics
  • Epicypher
  • Dolomite Bio
  • Fluxion Biosciences
  • Celsee
  • Rare Cyte
  • Akoya Biosciences
  • Menarini Silicon Biosystems
  • Parse Biosciences
  • Proteona

第九章：关于我们

简介目录
Product Code: GIS20532

Single-cell Analysis Market is anticipated to expand from $3.1 billion in 2024 to $11.0 billion by 2034, growing at a CAGR of approximately 12.7%. The Single-cell Analysis Market encompasses technologies and methodologies for examining individual cells, providing insights into cellular heterogeneity and microenvironments. This market includes instruments, consumables, and software that facilitate genomic, transcriptomic, and proteomic analyses at the single-cell level. Rising demand for precision medicine and advancements in biotechnology are propelling growth, with applications in oncology, immunology, and stem cell research. The market is characterized by innovations in microfluidics, sequencing technologies, and bioinformatics, driving enhanced resolution and throughput in cellular analysis.

The Single-cell Analysis Market is experiencing robust growth, propelled by advancements in genomic technologies and personalized medicine. Within this market, the consumables segment emerges as the top-performing category, with reagents and assay kits driving significant demand due to their essential role in single-cell experiments. Instruments, particularly flow cytometers and next-generation sequencing platforms, follow closely, reflecting their critical function in data acquisition and analysis. The software and services segment is gaining momentum, with bioinformatics tools and data analytics services becoming increasingly indispensable for interpreting complex single-cell data. Additionally, the oncology application segment leads in performance, driven by the need for precise cancer diagnostics and treatment strategies. Immunology applications are also on the rise, underscoring the importance of immune profiling in disease research. The growing emphasis on single-cell RNA sequencing further fuels market expansion, offering unparalleled insights into cellular heterogeneity and function.

Market Segmentation
TypeConsumables, Instruments, Software
ProductReagents, Assay Kits, Microplates, Beads, Instruments
ServicesCell Isolation, Single-cell Genomics, Single-cell Proteomics, Single-cell Transcriptomics
TechnologyFlow Cytometry, Mass Spectrometry, Microscopy, Next-generation Sequencing
ApplicationCancer Research, Neurology, Immunology, Stem Cell Research, Microbiology
End UserAcademic & Research Laboratories, Biotechnology & Pharmaceutical Companies, Hospitals & Diagnostic Laboratories
ComponentHardware, Software, Services
ProcessCell Viability Assessment, Cell Identification, Cell Counting
ModeAutomated, Manual

The Single-cell Analysis Market is characterized by a dynamic landscape, with significant market share held by leading biotechnology firms. Pricing strategies are competitive, reflecting the innovative nature of the sector and the introduction of new, cutting-edge technologies. Recent product launches have focused on enhancing precision and scalability, catering to the growing demand for personalized medicine and advanced research applications. The market is witnessing robust growth, driven by technological advancements and increased investment in research and development. Competition within the Single-cell Analysis Market is intense, with key players vying for dominance through strategic alliances and innovation. Regulatory influences, particularly in North America and Europe, shape market dynamics by setting stringent standards for product quality and safety. Benchmarking reveals that companies with strong R&D capabilities and comprehensive product portfolios maintain a competitive edge. The market is poised for continued expansion, propelled by the increasing adoption of single-cell technologies in oncology, immunology, and stem cell research. Challenges such as regulatory compliance and high operational costs persist, yet the potential for transformative medical breakthroughs presents lucrative opportunities.

Geographical Overview:

The single-cell analysis market is experiencing substantial growth across various regions, each presenting unique opportunities. North America leads the market due to advanced healthcare infrastructure and significant investments in genomics research. The presence of key industry players further enhances the region's position. Europe follows, driven by strong governmental support for research and development in biotechnology and personalized medicine. The Asia Pacific region is rapidly emerging, with countries like China and Japan at the forefront. Their investments in biotechnology and increasing healthcare expenditure are pivotal. These nations are also witnessing a surge in academic and research collaborations. Latin America and the Middle East & Africa are nascent markets with untapped potential. Brazil and South Africa are key players, focusing on improving healthcare infrastructure and research capabilities. These regions are also recognizing the importance of single-cell analysis in advancing precision medicine and genomic research, offering promising growth prospects.

Global tariffs and geopolitical tensions are profoundly influencing the Single-cell Analysis Market. In Japan and South Korea, trade frictions are encouraging investment in local biotechnological advancements to mitigate reliance on imports. China is accelerating its domestic R&D in single-cell technologies to counteract export restrictions, while Taiwan's strategic position in the semiconductor industry underpins its critical role in supply chains, despite geopolitical vulnerabilities. The parent market is experiencing robust growth, driven by increasing demand for precision medicine and personalized therapies globally. By 2035, the market is anticipated to evolve through enhanced regional collaborations and innovation in single-cell analytics. Meanwhile, Middle East conflicts may indirectly affect supply chains and energy prices, impacting operational costs and strategic planning in this high-growth sector.

Key Trends and Drivers:

The single-cell analysis market is experiencing remarkable growth, fueled by advancements in genomic technologies and personalized medicine. Key trends include the integration of artificial intelligence and machine learning, which enhance data analysis and interpretation, providing deeper insights into cellular behaviors. The demand for high-throughput sequencing technologies is also rising, enabling more comprehensive and cost-effective single-cell studies. Drivers of this market include the increasing prevalence of chronic diseases and the need for tailored therapeutic approaches. Researchers are focusing on understanding disease mechanisms at a cellular level, driving the adoption of single-cell analysis in oncology and immunology. Additionally, government funding and private investments are accelerating research and development activities, fostering innovation in this sector. The market is also witnessing a surge in collaborations between academic institutions and industry players, aiming to translate research findings into clinical applications. Opportunities are emerging in developing regions where healthcare infrastructure is improving, and research activities are expanding. Companies that offer scalable and user-friendly solutions are well-positioned to capture significant market share. The growing focus on precision medicine and early disease detection further underscores the potential for sustained growth in the single-cell analysis market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Consumables
    • 4.1.2 Instruments
    • 4.1.3 Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents
    • 4.2.2 Assay Kits
    • 4.2.3 Microplates
    • 4.2.4 Beads
    • 4.2.5 Instruments
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Cell Isolation
    • 4.3.2 Single-cell Genomics
    • 4.3.3 Single-cell Proteomics
    • 4.3.4 Single-cell Transcriptomics
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Flow Cytometry
    • 4.4.2 Mass Spectrometry
    • 4.4.3 Microscopy
    • 4.4.4 Next-generation Sequencing
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Cancer Research
    • 4.5.2 Neurology
    • 4.5.3 Immunology
    • 4.5.4 Stem Cell Research
    • 4.5.5 Microbiology
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Academic & Research Laboratories
    • 4.6.2 Biotechnology & Pharmaceutical Companies
    • 4.6.3 Hospitals & Diagnostic Laboratories
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Cell Viability Assessment
    • 4.8.2 Cell Identification
    • 4.8.3 Cell Counting
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 Automated
    • 4.9.2 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Process
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Process
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Process
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Process
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Process
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Process
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Process
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Process
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Process
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Process
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Process
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Process
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Process
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Process
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Process
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Process
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Process
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Process
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Process
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Process
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Process
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Process
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Process
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Process
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Fluidigm
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 10x Genomics
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mission Bio
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Bio- Rad Laboratories
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Takara Bio
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Nano String Technologies
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Illumina
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 BD Biosciences
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Berkeley Lights
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Cytek Biosciences
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 S2 Genomics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Epicypher
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Dolomite Bio
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Fluxion Biosciences
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Celsee
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Rare Cyte
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Akoya Biosciences
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Menarini Silicon Biosystems
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Parse Biosciences
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Proteona
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us